Evaluation of Gallbladder Adenocarcinoma by Next Generation Sequencing Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies
Publication
, Conference
Tarasen, AJ; Al-Rohil, RN; Wang, K; Rand, JV; Jones, DM; Lee, HJ; Sheehan, CE; Otto, GA; Palmer, G; Ali, SM; Morosini, D; Miller, VA ...
Published in: LABORATORY INVESTIGATION
February 1, 2014
Duke Scholars
Published In
LABORATORY INVESTIGATION
EISSN
1530-0307
ISSN
0023-6837
Publication Date
February 1, 2014
Volume
94
Start / End Page
205A / 206A
Location
San Diego, CA
Publisher
NATURE PUBLISHING GROUP
Conference Name
103rd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP)
Related Subject Headings
- Pathology
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Tarasen, A. J., Al-Rohil, R. N., Wang, K., Rand, J. V., Jones, D. M., Lee, H. J., … Ross, J. S. (2014). Evaluation of Gallbladder Adenocarcinoma by Next Generation Sequencing Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies. In LABORATORY INVESTIGATION (Vol. 94, pp. 205A-206A). San Diego, CA: NATURE PUBLISHING GROUP.
Tarasen, A. J., R. N. Al-Rohil, K. Wang, J. V. Rand, D. M. Jones, H. J. Lee, C. E. Sheehan, et al. “Evaluation of Gallbladder Adenocarcinoma by Next Generation Sequencing Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies.” In LABORATORY INVESTIGATION, 94:205A-206A. NATURE PUBLISHING GROUP, 2014.
Tarasen AJ, Al-Rohil RN, Wang K, Rand JV, Jones DM, Lee HJ, et al. Evaluation of Gallbladder Adenocarcinoma by Next Generation Sequencing Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies. In: LABORATORY INVESTIGATION. NATURE PUBLISHING GROUP; 2014. p. 205A-206A.
Tarasen, A. J., et al. “Evaluation of Gallbladder Adenocarcinoma by Next Generation Sequencing Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies.” LABORATORY INVESTIGATION, vol. 94, NATURE PUBLISHING GROUP, 2014, pp. 205A-206A.
Tarasen AJ, Al-Rohil RN, Wang K, Rand JV, Jones DM, Lee HJ, Sheehan CE, Otto GA, Palmer G, Ali SM, Morosini D, Miller VA, Stephens PJ, Ross JS. Evaluation of Gallbladder Adenocarcinoma by Next Generation Sequencing Reveals Frequent Actionable Genomic Abnormalities and New Routes to Targeted Therapies. LABORATORY INVESTIGATION. NATURE PUBLISHING GROUP; 2014. p. 205A-206A.
Published In
LABORATORY INVESTIGATION
EISSN
1530-0307
ISSN
0023-6837
Publication Date
February 1, 2014
Volume
94
Start / End Page
205A / 206A
Location
San Diego, CA
Publisher
NATURE PUBLISHING GROUP
Conference Name
103rd Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP)
Related Subject Headings
- Pathology
- 3202 Clinical sciences
- 1103 Clinical Sciences